IDH2 and central nervous system cancer: Using continuous measures of 18F-FDOPA PET, Patel et al. reported LN max and age as prognostic factors for OS in WHO grade I–IV gliomas, and that IDH or MGMT status did not correlate with uptake of 18F-FDOPA.